The device can simultaneously conduct PCR amplification and rapid, real-time fluorescence detection. Credit: Belova59 from Pixabay.

Materials and Machines Corporation (MatMaCorp) has introduced its new handheld device MY Real-Time Analyzer (MYRTA), which can carry out polymerase chain reaction (PCR) amplification and real-time fluorescent detection.

Weighing less than a pound and easily fitting in the hand, the device can identify DNA or RNA targets in an hour.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

MYRTA was developed to offer portable, PCR-based molecular diagnostic solutions for human and animal health. Using the existing testing format, it can process a sample with up to three different tests and offer near quantitative data, including a cycle threshold value.

Based on fluorescence detection technology, the device can run isothermal or PCR conditions (cycling between various temperatures), based on the various requirements for identifying DNA or RNA.

MatMaCorp founder and president Dr Abe Oommen said: “The ability to detect nucleic acids in real-time while running PCR amplification directly from the sample is a game changer in molecular diagnostics.

“Our flexible, robust and portable MYRTA device will enable the use of PCR in numerous situations, making point-of-care and over-the-counter PCR-based testing possible in any part of the globe.”

The device can simultaneously conduct PCR amplification and rapid, real-time fluorescence detection.

Apart from human health applications, the MYRTA system can be utilised in animal health, as it can potentially identify porcine reproductive and respiratory syndrome virus (PRRSV). PRRSV causes pigs to develop a major respiratory disease.

Over the next months, MatMaCorp intends to seek an emergency use authorization (EUA) for Covid-19 from the US Food and Drug Administration (FDA) for the MYRTA system.

In January, the FDA granted EUA to MatMaCorp’s Covid-19 2SF RNA test for SARS-CoV-2 detection on its Solas 8 portable detection system.